Pharmaceutical assistance programs to support smoking cessation medication access

Journal of the American Pharmacists Association

Volumn 57, Issue 1, 2017, Pages 67-71.e1

  Leon Salas, Angie ^a   Hunt, Jamie J ^a   Richter, Kimber P ^a   Nazir, Niaman ^a   Ellerbeck, Edward F ^a   Shireman, Theresa I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; INSURANCE; LOW DRUG DOSE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; PRESCRIPTION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCREENING; SMOKING CESSATION; ADULT; COMPARATIVE STUDY; COUNSELING; ECONOMICS; EPIDEMIOLOGY; FEMALE; HEALTH CARE DELIVERY; MALE; MEDICAL CARE; MIDDLE AGED; POVERTY; PREVENTION AND CONTROL; PROCEDURES; RURAL POPULATION; SMOKING; TELEMEDICINE; TELEPHONE; TIME FACTOR; TOBACCO USE DISORDER;

NICOTINE GUM;

ADULT; COUNSELING; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MEDICAL ASSISTANCE; MIDDLE AGED; POVERTY; RURAL POPULATION; SMOKING; SMOKING CESSATION; TELEMEDICINE; TELEPHONE; TIME FACTORS; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 85007556307     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1016/j.japh.2016.08.009     Document Type: Article

References (17)

1. 1 Blackwell, D.L., Lucas, J.W., Clarke, T.C., Summary health statistics for U.S. adults: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat 10:260 (2014), 69–72.
2. 2 Fiore, M.C., Jaen, C.R., Baker, T.B., et al. Treating tobacco use and dependence. Clinical practice guideline 2008 update. 2008, Public Health Service, U.S. Department of Health and Human Services, Rockville, MD.
3. 3 Quitting smoking among adults—United States, 2001-2010. MMWR Morb Mortal Wkly Rep 60:44 (2011), 1513–1519.
4. 4 DeNavas-Walt, C., Proctor, B.D., Smith, J.C., Income, poverty, and health insurance coverage in the United States: 2010. Washington, DC, 2011 Available at: https://www.census.gov/hhes/www/hlthins/data/incpovhlth/2010/index.html Accessed October 15, 2015.
5. 5 Hutcheson, T.D., Greiner, K.A., Ellerbeck, E.F., Jeffries, S.K., Mussulman, L.M., Casey, G.N., Understanding smoking cessation in rural communities. J Rural Health 24:2 (2008), 116–124.
6. 6 Johnson, P.E., Patient assistance programs and patient advocacy foundations: alternatives for obtaining prescription medications when insurance fails. Am J Health Syst Pharm 63:21 Suppl. 7 (2006), S13–S17.
7. 7 Chisholm, M.A., DiPiro, J.T., Pharmaceutical manufacturer assistance programs. Arch Intern Med 162:7 (2002), 780–784.
8. 8 Felder, T.M., Palmer, N.R., Lal, L.S., Mullen, P.D., What is the evidence for pharmaceutical patient assistance programs? A systematic review. J Health Care Poor Underserved 22:1 (2011), 24–49.
9. 9 Choudhry, N.K., Lee, J.L., Agnew-Blais, J., Corcoran, C., Shrank, W.H., Drug company-sponsored patient assistance programs: a viable safety net?. Health Aff Proj Hope 28:3 (2009), 827–834.
10. 10 Mussulman, L., Ellerbeck, E.F., Cupertino, A.P., Preacher, K.J., Spaulding, R., Catley, D., et al. Design and participant characteristics of a randomized-controlled trial of telemedicine for smoking cessation among rural smokers. Contemp Clin Trials 38:2 (2014), 173–181.
11. 11 Richter, K.P., Shireman, T.I., Ellerbeck, E.F., Cupertino, A.P., Catley, D., Cox, L.S., et al. Comparative and cost effectiveness of telemedicine versus telephone counseling for smoking cessation. J Med Internet Res, 17(5), 2015, e113.
12. 12 Barmford, J., Borland, R., Hammond, D., Cummings, K.M., Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC four country survey. Nicotine Tob Res 13 (2011), 94–103.
13. 13 Etter, J.F., Schneider, N.G., An internet survey of use, opinions and preferences for SCM: nicotine, varenicline, and bupropion. Nicotin Tob Res 15 (2013), 59–68.
14. 14 Duke, K.S., Raube, K., Lipton, H.L., Patient-assistance programs: assessment of and use by safety-net clinics. Am J Health Syst Pharm 62:7 (2005), 726–731.
15. 15 Omojasola, A., Hernandez, M., Sansgiry, S., Paxton, R., Jones, L., Predictors of $4 generic prescription drug discount programs use in the low-income population. Res Soc Adm Pharm 10:1 (2014), 141–148.
16. 16 Federman, A.D., Safran, D.G., Keyhani, S., Cole, H., Halm, E.A., Siu, A.L., Awareness of pharmaceutical cost-assistance programs among inner-city seniors. Am J Geriatr Pharmacother 7:2 (2009), 117–129.
17. 17 Pisu, M., Richman, J., Allison, J.J., Williams, O.D., Kiefe, C.I., Pharmaceuticals companies’ medication assistance programs: potentially useful but too burdensome to use?. South Med J 102:2 (2009), 139–144.